 Rachel Frank
Concepts (720)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shoulder Joint | 50 | 2024 | 163 | 10.050 |
Why?
| | Arthroscopy | 55 | 2024 | 211 | 9.780 |
Why?
| | Joint Instability | 36 | 2024 | 181 | 9.170 |
Why?
| | Knee Joint | 26 | 2023 | 366 | 4.920 |
Why?
| | Cartilage, Articular | 20 | 2023 | 297 | 4.850 |
Why?
| | Knee Injuries | 18 | 2022 | 98 | 4.840 |
Why?
| | Biological Products | 11 | 2023 | 202 | 4.620 |
Why?
| | Orthopedic Procedures | 19 | 2021 | 228 | 4.440 |
Why?
| | Shoulder Dislocation | 16 | 2023 | 49 | 4.360 |
Why?
| | Tibial Meniscus Injuries | 10 | 2022 | 45 | 3.880 |
Why?
| | Sports Medicine | 10 | 2023 | 110 | 3.760 |
Why?
| | Tibia | 12 | 2023 | 183 | 3.590 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 13 | 2023 | 125 | 3.490 |
Why?
| | Athletic Injuries | 20 | 2023 | 517 | 3.440 |
Why?
| | Platelet-Rich Plasma | 10 | 2023 | 32 | 3.420 |
Why?
| | Menisci, Tibial | 15 | 2022 | 58 | 3.360 |
Why?
| | Anterior Cruciate Ligament Injuries | 13 | 2023 | 141 | 3.250 |
Why?
| | Simulation Training | 6 | 2024 | 80 | 3.210 |
Why?
| | Orthopedics | 11 | 2021 | 141 | 3.180 |
Why?
| | Bone Transplantation | 12 | 2019 | 105 | 3.160 |
Why?
| | Femoracetabular Impingement | 8 | 2018 | 34 | 3.050 |
Why?
| | Rotator Cuff Injuries | 11 | 2023 | 56 | 2.670 |
Why?
| | Osteotomy | 10 | 2021 | 164 | 2.580 |
Why?
| | Hip Joint | 8 | 2018 | 159 | 2.510 |
Why?
| | Tenodesis | 8 | 2020 | 21 | 2.450 |
Why?
| | Cartilage Diseases | 5 | 2019 | 39 | 2.430 |
Why?
| | Reoperation | 29 | 2023 | 555 | 2.390 |
Why?
| | Arthroplasty | 10 | 2020 | 54 | 2.350 |
Why?
| | Meniscus | 4 | 2023 | 22 | 2.210 |
Why?
| | Osteoarthritis, Knee | 10 | 2023 | 233 | 2.190 |
Why?
| | Shoulder Injuries | 9 | 2024 | 56 | 2.060 |
Why?
| | Humans | 258 | 2024 | 129706 | 1.910 |
Why?
| | Shoulder | 22 | 2023 | 87 | 1.860 |
Why?
| | Arthroplasty, Replacement, Knee | 8 | 2023 | 271 | 1.850 |
Why?
| | Arthroplasty, Replacement, Shoulder | 9 | 2020 | 23 | 1.820 |
Why?
| | Allografts | 16 | 2023 | 138 | 1.800 |
Why?
| | Computer Simulation | 6 | 2021 | 947 | 1.770 |
Why?
| | Sports | 7 | 2023 | 227 | 1.680 |
Why?
| | Clinical Competence | 8 | 2024 | 1026 | 1.670 |
Why?
| | Tendons | 10 | 2020 | 127 | 1.640 |
Why?
| | Musculoskeletal Diseases | 4 | 2020 | 69 | 1.600 |
Why?
| | Return to Sport | 9 | 2023 | 91 | 1.600 |
Why?
| | Suture Anchors | 7 | 2021 | 33 | 1.600 |
Why?
| | Athletes | 7 | 2023 | 408 | 1.550 |
Why?
| | Scapula | 11 | 2023 | 45 | 1.550 |
Why?
| | Cartilage | 9 | 2021 | 182 | 1.550 |
Why?
| | Acromioclavicular Joint | 3 | 2023 | 11 | 1.540 |
Why?
| | Postoperative Complications | 24 | 2022 | 2500 | 1.460 |
Why?
| | Tendon Injuries | 5 | 2019 | 83 | 1.420 |
Why?
| | Transplantation, Homologous | 16 | 2023 | 404 | 1.410 |
Why?
| | Femur | 8 | 2023 | 242 | 1.270 |
Why?
| | Adult | 106 | 2023 | 35596 | 1.250 |
Why?
| | Young Adult | 49 | 2023 | 12363 | 1.200 |
Why?
| | Treatment Outcome | 45 | 2023 | 10299 | 1.200 |
Why?
| | Humeral Head | 7 | 2023 | 13 | 1.190 |
Why?
| | Bankart Lesions | 4 | 2023 | 9 | 1.150 |
Why?
| | Evidence-Based Medicine | 7 | 2020 | 731 | 1.150 |
Why?
| | Arthroplasty, Subchondral | 4 | 2018 | 7 | 1.140 |
Why?
| | Internship and Residency | 8 | 2024 | 1056 | 1.130 |
Why?
| | Rotator Cuff | 8 | 2023 | 44 | 1.120 |
Why?
| | Anterior Cruciate Ligament | 9 | 2023 | 82 | 1.110 |
Why?
| | Male | 134 | 2023 | 63544 | 1.080 |
Why?
| | Education, Medical, Graduate | 5 | 2019 | 438 | 1.070 |
Why?
| | Bone Malalignment | 1 | 2013 | 15 | 1.060 |
Why?
| | Female Athlete Triad Syndrome | 2 | 2017 | 7 | 1.060 |
Why?
| | Middle Aged | 92 | 2023 | 31103 | 1.050 |
Why?
| | Joint Dislocations | 2 | 2024 | 64 | 1.050 |
Why?
| | Bone Screws | 5 | 2020 | 126 | 1.040 |
Why?
| | Ligaments, Articular | 5 | 2023 | 59 | 1.040 |
Why?
| | Hemiarthroplasty | 3 | 2020 | 7 | 1.020 |
Why?
| | Osteoarthritis | 7 | 2019 | 180 | 1.010 |
Why?
| | Female | 129 | 2022 | 68562 | 1.000 |
Why?
| | Range of Motion, Articular | 17 | 2023 | 387 | 0.990 |
Why?
| | Orthopedic Surgeons | 2 | 2023 | 26 | 0.960 |
Why?
| | Achilles Tendon | 2 | 2023 | 41 | 0.930 |
Why?
| | Blood Loss, Surgical | 2 | 2014 | 91 | 0.890 |
Why?
| | Biomechanical Phenomena | 16 | 2023 | 783 | 0.880 |
Why?
| | Quadriceps Muscle | 2 | 2023 | 126 | 0.860 |
Why?
| | Follow-Up Studies | 33 | 2021 | 4939 | 0.850 |
Why?
| | Cadaver | 13 | 2020 | 336 | 0.840 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2014 | 121 | 0.810 |
Why?
| | Adolescent | 65 | 2023 | 20355 | 0.800 |
Why?
| | Venous Thrombosis | 2 | 2022 | 165 | 0.800 |
Why?
| | Retrospective Studies | 53 | 2021 | 14669 | 0.780 |
Why?
| | Lacerations | 1 | 2022 | 30 | 0.770 |
Why?
| | Pain | 5 | 2018 | 770 | 0.720 |
Why?
| | Golf | 1 | 2020 | 7 | 0.700 |
Why?
| | Bone Resorption | 3 | 2018 | 77 | 0.700 |
Why?
| | Skiing | 1 | 2021 | 45 | 0.690 |
Why?
| | Rupture | 8 | 2023 | 101 | 0.690 |
Why?
| | Brain Concussion | 4 | 2023 | 544 | 0.680 |
Why?
| | Suture Techniques | 8 | 2019 | 121 | 0.670 |
Why?
| | Radiography | 14 | 2019 | 863 | 0.670 |
Why?
| | Hamstring Muscles | 2 | 2018 | 17 | 0.660 |
Why?
| | Internet | 3 | 2022 | 647 | 0.650 |
Why?
| | Physical Examination | 9 | 2018 | 240 | 0.630 |
Why?
| | Social Media | 1 | 2022 | 148 | 0.630 |
Why?
| | Humerus | 7 | 2020 | 41 | 0.630 |
Why?
| | Hypertension | 10 | 2023 | 1240 | 0.620 |
Why?
| | Aged | 61 | 2021 | 22113 | 0.610 |
Why?
| | Virtual Reality | 1 | 2019 | 51 | 0.610 |
Why?
| | Pain, Postoperative | 2 | 2018 | 227 | 0.600 |
Why?
| | Tenotomy | 1 | 2018 | 13 | 0.590 |
Why?
| | Swimming | 1 | 2018 | 47 | 0.590 |
Why?
| | Adipose Tissue | 3 | 2019 | 588 | 0.590 |
Why?
| | Patient Reported Outcome Measures | 8 | 2020 | 359 | 0.590 |
Why?
| | Prosthesis Failure | 5 | 2015 | 120 | 0.590 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 273 | 0.590 |
Why?
| | Yoga | 1 | 2018 | 30 | 0.580 |
Why?
| | Glenoid Cavity | 2 | 2015 | 7 | 0.570 |
Why?
| | Treatment Failure | 6 | 2020 | 347 | 0.570 |
Why?
| | Leg Injuries | 1 | 2017 | 28 | 0.570 |
Why?
| | Imaging, Three-Dimensional | 4 | 2018 | 559 | 0.560 |
Why?
| | Bone Density | 2 | 2021 | 470 | 0.560 |
Why?
| | Fractures, Stress | 1 | 2017 | 32 | 0.560 |
Why?
| | Stress, Mechanical | 3 | 2019 | 470 | 0.560 |
Why?
| | Olecranon Process | 1 | 2017 | 7 | 0.550 |
Why?
| | Muscle, Skeletal | 8 | 2020 | 1632 | 0.550 |
Why?
| | Prosthesis-Related Infections | 2 | 2015 | 80 | 0.550 |
Why?
| | Ulna Fractures | 1 | 2017 | 14 | 0.550 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2019 | 50 | 0.540 |
Why?
| | Fractures, Ununited | 1 | 2017 | 31 | 0.540 |
Why?
| | Injections, Intra-Articular | 6 | 2023 | 45 | 0.540 |
Why?
| | Hip | 3 | 2014 | 55 | 0.540 |
Why?
| | Open Fracture Reduction | 1 | 2017 | 31 | 0.540 |
Why?
| | Bicycling | 1 | 2017 | 118 | 0.530 |
Why?
| | Databases, Factual | 10 | 2019 | 1297 | 0.530 |
Why?
| | Cumulative Trauma Disorders | 1 | 2017 | 41 | 0.530 |
Why?
| | Chondrocytes | 2 | 2018 | 203 | 0.530 |
Why?
| | Carcinoma, Renal Cell | 3 | 2019 | 181 | 0.510 |
Why?
| | Osteosarcoma | 2 | 2015 | 75 | 0.510 |
Why?
| | Soft Tissue Injuries | 1 | 2016 | 37 | 0.500 |
Why?
| | Patellar Ligament | 2 | 2014 | 25 | 0.490 |
Why?
| | Transplantation, Autologous | 6 | 2023 | 214 | 0.490 |
Why?
| | Comprehension | 2 | 2014 | 170 | 0.490 |
Why?
| | Stereotyping | 1 | 2015 | 48 | 0.490 |
Why?
| | Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 2 | 0.480 |
Why?
| | Prejudice | 1 | 2015 | 70 | 0.480 |
Why?
| | Cohort Studies | 13 | 2023 | 5410 | 0.470 |
Why?
| | Ilium | 1 | 2014 | 29 | 0.460 |
Why?
| | Arthroplasty, Replacement | 5 | 2016 | 47 | 0.460 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 5 | 2023 | 84 | 0.460 |
Why?
| | Fracture Fixation, Internal | 1 | 2017 | 219 | 0.450 |
Why?
| | Hip Injuries | 1 | 2014 | 15 | 0.450 |
Why?
| | Incidence | 11 | 2022 | 2658 | 0.450 |
Why?
| | Kidney Transplantation | 5 | 2022 | 638 | 0.450 |
Why?
| | Patellofemoral Joint | 2 | 2023 | 8 | 0.440 |
Why?
| | Kidney Neoplasms | 3 | 2019 | 352 | 0.440 |
Why?
| | Hip Prosthesis | 1 | 2014 | 34 | 0.440 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2014 | 739 | 0.440 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 24 | 0.440 |
Why?
| | Patient Satisfaction | 3 | 2018 | 642 | 0.430 |
Why?
| | Materials Testing | 2 | 2017 | 343 | 0.430 |
Why?
| | Time-to-Treatment | 1 | 2015 | 182 | 0.430 |
Why?
| | Models, Educational | 1 | 2013 | 84 | 0.420 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 63 | 0.420 |
Why?
| | Patient Education as Topic | 3 | 2019 | 745 | 0.420 |
Why?
| | Bone and Bones | 1 | 2016 | 297 | 0.420 |
Why?
| | Recurrence | 15 | 2023 | 1016 | 0.420 |
Why?
| | Pain Management | 2 | 2014 | 327 | 0.410 |
Why?
| | Graft Survival | 6 | 2019 | 525 | 0.410 |
Why?
| | Liposarcoma | 1 | 2013 | 27 | 0.410 |
Why?
| | Models, Anatomic | 1 | 2013 | 94 | 0.410 |
Why?
| | Acetabulum | 2 | 2014 | 103 | 0.410 |
Why?
| | Child | 45 | 2023 | 20963 | 0.400 |
Why?
| | Femur Head | 1 | 2012 | 38 | 0.400 |
Why?
| | Postoperative Period | 7 | 2019 | 320 | 0.400 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 126 | 0.400 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 55 | 0.400 |
Why?
| | Pain Measurement | 6 | 2018 | 497 | 0.400 |
Why?
| | Femur Neck | 1 | 2012 | 59 | 0.400 |
Why?
| | Universities | 1 | 2014 | 408 | 0.390 |
Why?
| | Nephrectomy | 1 | 2013 | 163 | 0.380 |
Why?
| | Musculoskeletal System | 2 | 2022 | 46 | 0.370 |
Why?
| | Rotation | 3 | 2018 | 118 | 0.370 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2539 | 0.370 |
Why?
| | Hyaluronic Acid | 6 | 2023 | 214 | 0.370 |
Why?
| | Blood Pressure | 6 | 2023 | 1747 | 0.360 |
Why?
| | Age Factors | 11 | 2019 | 3145 | 0.360 |
Why?
| | Activities of Daily Living | 4 | 2018 | 383 | 0.350 |
Why?
| | Surveys and Questionnaires | 7 | 2022 | 5396 | 0.350 |
Why?
| | Football | 3 | 2017 | 78 | 0.340 |
Why?
| | Risk Factors | 20 | 2022 | 9832 | 0.330 |
Why?
| | Stem Cell Transplantation | 3 | 2020 | 168 | 0.330 |
Why?
| | Random Allocation | 4 | 2019 | 353 | 0.330 |
Why?
| | Meniscectomy | 2 | 2019 | 7 | 0.320 |
Why?
| | Joint Prosthesis | 3 | 2015 | 26 | 0.320 |
Why?
| | Pilot Projects | 7 | 2021 | 1567 | 0.320 |
Why?
| | Delphi Technique | 7 | 2023 | 219 | 0.320 |
Why?
| | Health Care Surveys | 3 | 2017 | 564 | 0.320 |
Why?
| | Nephrotic Syndrome | 3 | 2022 | 28 | 0.310 |
Why?
| | United States | 19 | 2020 | 14078 | 0.310 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2023 | 127 | 0.300 |
Why?
| | Physical Therapy Modalities | 3 | 2023 | 293 | 0.300 |
Why?
| | Mass Screening | 2 | 2014 | 1130 | 0.300 |
Why?
| | Consensus | 3 | 2022 | 646 | 0.300 |
Why?
| | Body Mass Index | 5 | 2019 | 2246 | 0.290 |
Why?
| | Reproducibility of Results | 7 | 2023 | 3054 | 0.290 |
Why?
| | Second-Look Surgery | 2 | 2017 | 7 | 0.290 |
Why?
| | Patient Readmission | 3 | 2018 | 675 | 0.280 |
Why?
| | Sex Factors | 5 | 2019 | 1952 | 0.280 |
Why?
| | Aged, 80 and over | 20 | 2021 | 7074 | 0.280 |
Why?
| | Magnetic Resonance Imaging | 4 | 2019 | 3351 | 0.280 |
Why?
| | Joint Diseases | 3 | 2019 | 60 | 0.270 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 52 | 0.270 |
Why?
| | Infant Mortality | 1 | 2004 | 97 | 0.260 |
Why?
| | Patient Positioning | 2 | 2019 | 51 | 0.260 |
Why?
| | Arthralgia | 1 | 2014 | 52 | 0.260 |
Why?
| | Matched-Pair Analysis | 2 | 2016 | 45 | 0.250 |
Why?
| | Electrocoagulation | 4 | 2014 | 37 | 0.240 |
Why?
| | Pulmonary Embolism | 3 | 2018 | 214 | 0.240 |
Why?
| | Wound Healing | 3 | 2013 | 310 | 0.240 |
Why?
| | Viscosupplements | 3 | 2020 | 10 | 0.230 |
Why?
| | Humeral Fractures | 2 | 2017 | 48 | 0.230 |
Why?
| | Catheter Ablation | 4 | 1996 | 325 | 0.230 |
Why?
| | Tachycardia, Ventricular | 3 | 1996 | 167 | 0.230 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1008 | 0.230 |
Why?
| | Risk Assessment | 7 | 2020 | 3297 | 0.230 |
Why?
| | Curriculum | 2 | 2021 | 933 | 0.230 |
Why?
| | Prognosis | 12 | 2020 | 3801 | 0.230 |
Why?
| | Reading | 3 | 2014 | 150 | 0.220 |
Why?
| | Patellar Dislocation | 1 | 2023 | 6 | 0.220 |
Why?
| | Bone Marrow | 3 | 2023 | 264 | 0.220 |
Why?
| | Prehypertension | 1 | 2023 | 27 | 0.220 |
Why?
| | Time Factors | 17 | 2019 | 6593 | 0.220 |
Why?
| | Sutures | 3 | 2019 | 53 | 0.210 |
Why?
| | Urolithiasis | 2 | 2016 | 9 | 0.210 |
Why?
| | Debridement | 4 | 2017 | 87 | 0.200 |
Why?
| | Heart Ventricles | 4 | 2019 | 779 | 0.200 |
Why?
| | Postoperative Care | 4 | 2019 | 248 | 0.200 |
Why?
| | Recovery of Function | 7 | 2019 | 643 | 0.200 |
Why?
| | Ankle Injuries | 1 | 2023 | 81 | 0.200 |
Why?
| | Research Design | 2 | 2018 | 1048 | 0.200 |
Why?
| | Intra-Articular Fractures | 2 | 2019 | 19 | 0.190 |
Why?
| | Preoperative Period | 2 | 2018 | 113 | 0.190 |
Why?
| | Urinary Diversion | 2 | 1998 | 12 | 0.180 |
Why?
| | Osteoarthritis, Hip | 1 | 2021 | 43 | 0.180 |
Why?
| | Glomerulosclerosis, Focal Segmental | 2 | 2016 | 42 | 0.180 |
Why?
| | Knee Dislocation | 1 | 2021 | 7 | 0.180 |
Why?
| | Verbal Learning | 2 | 2007 | 64 | 0.180 |
Why?
| | Biology | 1 | 2022 | 82 | 0.180 |
Why?
| | Comorbidity | 5 | 2018 | 1545 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2022 | 1379 | 0.180 |
Why?
| | Operating Rooms | 2 | 2024 | 110 | 0.180 |
Why?
| | Drug Chronotherapy | 1 | 2020 | 1 | 0.180 |
Why?
| | Arm | 2 | 2019 | 107 | 0.180 |
Why?
| | Ankle | 2 | 2019 | 79 | 0.180 |
Why?
| | Socioeconomic Factors | 1 | 2004 | 1212 | 0.180 |
Why?
| | Artificial Intelligence | 1 | 2023 | 235 | 0.180 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | | | 37 | NaN |
Why?
| | Antihypertensive Agents | 2 | 2020 | 487 | 0.170 |
Why?
| | Marketing of Health Services | 1 | 2020 | 14 | 0.170 |
Why?
| | Echocardiography | 4 | 2020 | 635 | 0.170 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2020 | 6 | 0.170 |
Why?
| | Multiple Trauma | 1 | 2021 | 103 | 0.170 |
Why?
| | Algorithms | 3 | 2023 | 1632 | 0.170 |
Why?
| | Delayed Graft Function | 2 | 2018 | 30 | 0.170 |
Why?
| | Autografts | 2 | 2023 | 42 | 0.170 |
Why?
| | Absorptiometry, Photon | 1 | 2021 | 250 | 0.170 |
Why?
| | Osteonecrosis | 1 | 2020 | 23 | 0.170 |
Why?
| | Kidney | 6 | 2016 | 1330 | 0.160 |
Why?
| | Intraoperative Complications | 2 | 2012 | 133 | 0.160 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 29 | 0.160 |
Why?
| | Bone Substitutes | 1 | 2019 | 27 | 0.160 |
Why?
| | Tensile Strength | 1 | 2019 | 97 | 0.160 |
Why?
| | Workers' Compensation | 1 | 2019 | 27 | 0.160 |
Why?
| | Surgeons | 1 | 2023 | 279 | 0.150 |
Why?
| | Prospective Studies | 5 | 2023 | 7131 | 0.150 |
Why?
| | Immunosuppressive Agents | 3 | 2008 | 706 | 0.150 |
Why?
| | Graft Rejection | 3 | 2018 | 569 | 0.150 |
Why?
| | Pudendal Nerve | 1 | 2018 | 2 | 0.150 |
Why?
| | Shoulder Impingement Syndrome | 2 | 2018 | 7 | 0.150 |
Why?
| | Acromion | 2 | 2017 | 7 | 0.150 |
Why?
| | Visual Analog Scale | 1 | 2018 | 29 | 0.150 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 246 | 0.150 |
Why?
| | Odds Ratio | 2 | 2018 | 1025 | 0.150 |
Why?
| | Prosthesis Design | 3 | 2015 | 322 | 0.150 |
Why?
| | Mycophenolic Acid | 3 | 2008 | 95 | 0.150 |
Why?
| | Osteochondritis Dissecans | 1 | 2018 | 10 | 0.150 |
Why?
| | Radius | 1 | 2018 | 36 | 0.150 |
Why?
| | Thinness | 1 | 2018 | 89 | 0.150 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 228 | 0.150 |
Why?
| | Urinary Bladder Diseases | 1 | 1998 | 18 | 0.150 |
Why?
| | Spine | 1 | 2019 | 155 | 0.150 |
Why?
| | Arthrography | 1 | 2017 | 17 | 0.140 |
Why?
| | Bone Marrow Transplantation | 1 | 2019 | 267 | 0.140 |
Why?
| | Length of Stay | 3 | 2018 | 1133 | 0.140 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 292 | 0.140 |
Why?
| | Multiple Sclerosis | 3 | 2008 | 429 | 0.140 |
Why?
| | Hospital Charges | 1 | 2017 | 41 | 0.140 |
Why?
| | Anticoagulants | 1 | 2022 | 623 | 0.140 |
Why?
| | Nephrons | 1 | 2016 | 17 | 0.140 |
Why?
| | Hypercalciuria | 1 | 2016 | 2 | 0.140 |
Why?
| | Cross-Sectional Studies | 7 | 2023 | 5050 | 0.130 |
Why?
| | Patient Safety | 1 | 2020 | 292 | 0.130 |
Why?
| | Dementia | 1 | 2000 | 230 | 0.130 |
Why?
| | Orthopedic Fixation Devices | 1 | 2016 | 8 | 0.130 |
Why?
| | Fever | 2 | 2017 | 301 | 0.130 |
Why?
| | Shoulder Fractures | 1 | 2016 | 12 | 0.130 |
Why?
| | Medical History Taking | 2 | 2014 | 122 | 0.130 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 253 | 0.130 |
Why?
| | Elbow Joint | 1 | 2016 | 65 | 0.130 |
Why?
| | Child, Preschool | 18 | 2018 | 10565 | 0.130 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 173 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2019 | 3363 | 0.120 |
Why?
| | Kidney Failure, Chronic | 3 | 2018 | 548 | 0.120 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1442 | 0.120 |
Why?
| | Tendinopathy | 1 | 2015 | 24 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2023 | 645 | 0.120 |
Why?
| | Femoral Neck Fractures | 1 | 2015 | 22 | 0.120 |
Why?
| | Femoral Neoplasms | 1 | 2015 | 10 | 0.120 |
Why?
| | Kidney Diseases | 2 | 2009 | 367 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 340 | 0.120 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 11 | 0.120 |
Why?
| | Limb Salvage | 1 | 2015 | 59 | 0.120 |
Why?
| | Ontario | 3 | 2023 | 94 | 0.120 |
Why?
| | Fracture Fixation | 1 | 2015 | 82 | 0.120 |
Why?
| | Hemodilution | 1 | 2014 | 9 | 0.120 |
Why?
| | Glomerular Filtration Rate | 5 | 2020 | 684 | 0.120 |
Why?
| | Circadian Rhythm | 2 | 2016 | 402 | 0.110 |
Why?
| | Journal Impact Factor | 1 | 2014 | 31 | 0.110 |
Why?
| | Hemostasis, Surgical | 1 | 2014 | 19 | 0.110 |
Why?
| | Spinal Stenosis | 1 | 2014 | 26 | 0.110 |
Why?
| | Arthritis | 2 | 2016 | 113 | 0.110 |
Why?
| | Laser Coagulation | 1 | 2014 | 57 | 0.110 |
Why?
| | Intervertebral Disc Displacement | 1 | 2014 | 37 | 0.110 |
Why?
| | Military Personnel | 2 | 2020 | 608 | 0.110 |
Why?
| | Tourniquets | 1 | 2014 | 31 | 0.110 |
Why?
| | Running | 1 | 2016 | 230 | 0.110 |
Why?
| | Electromyography | 1 | 2016 | 380 | 0.110 |
Why?
| | Hemostatics | 1 | 2014 | 50 | 0.110 |
Why?
| | Malnutrition | 1 | 2015 | 79 | 0.110 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 328 | 0.110 |
Why?
| | Prostheses and Implants | 1 | 2015 | 140 | 0.110 |
Why?
| | Professional Practice | 1 | 2014 | 66 | 0.110 |
Why?
| | Health Status Disparities | 1 | 2016 | 246 | 0.110 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 84 | 0.110 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 149 | 0.110 |
Why?
| | Canada | 1 | 2014 | 355 | 0.110 |
Why?
| | Pressure | 1 | 2014 | 238 | 0.110 |
Why?
| | Learning Curve | 1 | 2013 | 68 | 0.110 |
Why?
| | Athletic Performance | 1 | 2014 | 77 | 0.110 |
Why?
| | Societies, Medical | 2 | 2014 | 763 | 0.110 |
Why?
| | Adrenal Cortex Hormones | 2 | 2015 | 526 | 0.100 |
Why?
| | Gait | 1 | 2016 | 284 | 0.100 |
Why?
| | Metals | 1 | 2014 | 126 | 0.100 |
Why?
| | Tachycardia | 3 | 1989 | 54 | 0.100 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1507 | 0.100 |
Why?
| | Watchful Waiting | 1 | 2012 | 66 | 0.100 |
Why?
| | Incidental Findings | 1 | 2013 | 80 | 0.100 |
Why?
| | Pneumonia | 1 | 2018 | 613 | 0.100 |
Why?
| | Arthrometry, Articular | 1 | 2012 | 10 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 729 | 0.100 |
Why?
| | Popliteal Vein | 1 | 2012 | 4 | 0.100 |
Why?
| | Nutritional Status | 1 | 2015 | 327 | 0.100 |
Why?
| | Posterior Cruciate Ligament | 1 | 2012 | 12 | 0.100 |
Why?
| | Educational Measurement | 1 | 2014 | 259 | 0.100 |
Why?
| | Locomotion | 1 | 2012 | 99 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1526 | 0.100 |
Why?
| | Osseointegration | 1 | 2012 | 56 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2012 | 163 | 0.090 |
Why?
| | Popliteal Artery | 1 | 2012 | 60 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2014 | 210 | 0.090 |
Why?
| | Prednisone | 3 | 2007 | 241 | 0.090 |
Why?
| | Smoking | 1 | 2018 | 1507 | 0.090 |
Why?
| | Tooth | 2 | 1990 | 41 | 0.090 |
Why?
| | Sexual Behavior | 1 | 2015 | 483 | 0.090 |
Why?
| | Disability Evaluation | 1 | 2012 | 291 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2022 | 0.080 |
Why?
| | Reference Standards | 1 | 2010 | 168 | 0.080 |
Why?
| | Ankle Joint | 2 | 2023 | 172 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 95 | 0.080 |
Why?
| | Lead | 1 | 1990 | 55 | 0.080 |
Why?
| | Arrhythmias, Cardiac | 3 | 1996 | 312 | 0.080 |
Why?
| | Bicuspid | 2 | 1988 | 16 | 0.080 |
Why?
| | Proteinuria | 2 | 2007 | 89 | 0.080 |
Why?
| | Molar | 2 | 1988 | 49 | 0.080 |
Why?
| | Referral and Consultation | 2 | 2012 | 731 | 0.080 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 295 | 0.080 |
Why?
| | Transplant Recipients | 2 | 2022 | 157 | 0.080 |
Why?
| | Biopsy, Needle | 1 | 2009 | 192 | 0.080 |
Why?
| | Naturopathy | 1 | 2008 | 1 | 0.080 |
Why?
| | Sepsis | 1 | 2015 | 566 | 0.080 |
Why?
| | Pesticide Residues | 1 | 1988 | 3 | 0.080 |
Why?
| | Mexico | 2 | 2004 | 188 | 0.080 |
Why?
| | Transillumination | 1 | 1988 | 3 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 421 | 0.070 |
Why?
| | Urologic Diseases | 1 | 2008 | 38 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1113 | 0.070 |
Why?
| | Urography | 2 | 1998 | 15 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2019 | 996 | 0.070 |
Why?
| | Heart Arrest | 2 | 2012 | 331 | 0.070 |
Why?
| | Insecticides | 1 | 1988 | 34 | 0.070 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2007 | 2 | 0.070 |
Why?
| | Leptospira interrogans | 2 | 1985 | 4 | 0.070 |
Why?
| | Systole | 2 | 2019 | 190 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2008 | 105 | 0.070 |
Why?
| | Ginkgo biloba | 1 | 2007 | 6 | 0.070 |
Why?
| | Dental Caries | 2 | 1988 | 176 | 0.070 |
Why?
| | Severity of Illness Index | 5 | 2016 | 2783 | 0.070 |
Why?
| | Hospitalization | 2 | 2016 | 2091 | 0.070 |
Why?
| | Logistic Models | 2 | 2015 | 1980 | 0.070 |
Why?
| | Milk, Human | 1 | 1988 | 146 | 0.070 |
Why?
| | Lysholm Knee Score | 2 | 2016 | 8 | 0.070 |
Why?
| | Sleep | 2 | 2022 | 657 | 0.070 |
Why?
| | Reagent Strips | 1 | 2006 | 6 | 0.070 |
Why?
| | Fatigue | 1 | 2008 | 320 | 0.060 |
Why?
| | Depressive Disorder | 2 | 2006 | 361 | 0.060 |
Why?
| | Urine | 1 | 2006 | 57 | 0.060 |
Why?
| | Dental Enamel | 3 | 1990 | 69 | 0.060 |
Why?
| | Ligaments | 2 | 2020 | 54 | 0.060 |
Why?
| | Nephrosis, Lipoid | 1 | 2005 | 10 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2851 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1287 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 179 | 0.060 |
Why?
| | Return to Work | 2 | 2015 | 19 | 0.060 |
Why?
| | Hyperparathyroidism | 1 | 2004 | 13 | 0.060 |
Why?
| | Creatinine | 2 | 2008 | 485 | 0.060 |
Why?
| | Shoulder Pain | 2 | 2018 | 32 | 0.060 |
Why?
| | Leukocytes | 1 | 2006 | 301 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1529 | 0.060 |
Why?
| | Probability | 1 | 2006 | 315 | 0.060 |
Why?
| | Weil Disease | 1 | 1983 | 1 | 0.060 |
Why?
| | Maternal Age | 1 | 2004 | 122 | 0.060 |
Why?
| | Acidosis, Renal Tubular | 1 | 2003 | 5 | 0.060 |
Why?
| | Joint Capsule | 2 | 2016 | 11 | 0.060 |
Why?
| | Parathyroid Hormone | 1 | 2004 | 100 | 0.060 |
Why?
| | Cognition Disorders | 1 | 2008 | 496 | 0.060 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 35 | 0.060 |
Why?
| | Failure to Thrive | 1 | 2003 | 31 | 0.050 |
Why?
| | Bicarbonates | 1 | 2003 | 44 | 0.050 |
Why?
| | Social Justice | 1 | 2004 | 79 | 0.050 |
Why?
| | Felodipine | 1 | 2003 | 4 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2003 | 26 | 0.050 |
Why?
| | Blood Chemical Analysis | 1 | 2003 | 94 | 0.050 |
Why?
| | Nephrology | 1 | 2003 | 57 | 0.050 |
Why?
| | Regression Analysis | 3 | 2016 | 992 | 0.050 |
Why?
| | Health Status | 1 | 2008 | 751 | 0.050 |
Why?
| | Immobilization | 1 | 2023 | 44 | 0.050 |
Why?
| | Urinalysis | 2 | 2016 | 70 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 1983 | 145 | 0.050 |
Why?
| | Injections | 1 | 2023 | 174 | 0.050 |
Why?
| | Evaluation Studies as Topic | 3 | 1998 | 175 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2023 | 330 | 0.050 |
Why?
| | Nephritis, Hereditary | 1 | 2002 | 1 | 0.050 |
Why?
| | Infant | 7 | 2013 | 9097 | 0.050 |
Why?
| | Enalapril | 1 | 2002 | 17 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 311 | 0.050 |
Why?
| | Emergencies | 1 | 2023 | 164 | 0.050 |
Why?
| | Electrocardiography | 1 | 1989 | 607 | 0.050 |
Why?
| | Nitrites | 1 | 2002 | 81 | 0.050 |
Why?
| | Forecasting | 1 | 2023 | 364 | 0.050 |
Why?
| | Urinary Tract Infections | 1 | 2003 | 147 | 0.050 |
Why?
| | Radionuclide Angiography | | | 5 | NaN |
Why?
| | Confidence Intervals | 2 | 2016 | 319 | 0.050 |
Why?
| | Weight-Bearing | 2 | 2013 | 183 | 0.050 |
Why?
| | Dentin | 2 | 1990 | 23 | 0.050 |
Why?
| | Cognition | 2 | 2007 | 1098 | 0.040 |
Why?
| | Albuminuria | 1 | 2002 | 180 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 207 | 0.040 |
Why?
| | Heart Function Tests | | | 61 | NaN |
Why?
| | Poverty | 1 | 2004 | 493 | 0.040 |
Why?
| | Mental Status Schedule | 1 | 2000 | 34 | 0.040 |
Why?
| | Language Tests | 1 | 2000 | 31 | 0.040 |
Why?
| | Heart Diseases | 1 | 2004 | 356 | 0.040 |
Why?
| | Complement Activation | 1 | 2023 | 359 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2020 | 30 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2000 | 1981 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 1999 | 21 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 396 | 0.040 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2003 | 242 | 0.040 |
Why?
| | Quality of Life | 2 | 2015 | 2712 | 0.040 |
Why?
| | Aggrecans | 1 | 2019 | 14 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2018 | 1849 | 0.040 |
Why?
| | Survival Rate | | | 1894 | NaN |
Why?
| | Depression | 1 | 2008 | 1290 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 462 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 164 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 264 | 0.040 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 78 | 0.040 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 14 | 0.040 |
Why?
| | Urinary Bladder | 2 | 1998 | 175 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 152 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 108 | 0.040 |
Why?
| | Serum | 1 | 2019 | 57 | 0.040 |
Why?
| | Research Subjects | 1 | 2018 | 44 | 0.040 |
Why?
| | ROC Curve | 1 | 2000 | 503 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | | | 226 | NaN |
Why?
| | Calcium | 1 | 2004 | 1182 | 0.040 |
Why?
| | Deltoid Muscle | 1 | 2017 | 6 | 0.040 |
Why?
| | Benzophenones | 1 | 2017 | 16 | 0.040 |
Why?
| | Thigh | 1 | 2018 | 54 | 0.040 |
Why?
| | Cystoscopy | 1 | 1998 | 18 | 0.040 |
Why?
| | Pectoralis Muscles | 1 | 2017 | 17 | 0.040 |
Why?
| | Sciatic Nerve | 1 | 2018 | 59 | 0.040 |
Why?
| | Radiographic Image Enhancement | 1 | 1998 | 58 | 0.040 |
Why?
| | Anatomic Landmarks | 1 | 2017 | 28 | 0.040 |
Why?
| | Demography | 1 | 2018 | 282 | 0.040 |
Why?
| | Dissection | 1 | 2018 | 55 | 0.040 |
Why?
| | Brachial Plexus | 1 | 2017 | 28 | 0.040 |
Why?
| | Torque | 1 | 2017 | 85 | 0.040 |
Why?
| | Ketones | 1 | 2017 | 47 | 0.040 |
Why?
| | Biomarkers | 3 | 2019 | 3893 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 612 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1288 | 0.040 |
Why?
| | Proportional Hazards Models | | | 1227 | NaN |
Why?
| | User-Computer Interface | 1 | 1998 | 149 | 0.030 |
Why?
| | White Coat Hypertension | 1 | 2016 | 6 | 0.030 |
Why?
| | Video Recording | 1 | 1998 | 170 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 261 | 0.030 |
Why?
| | Tarsal Bones | 1 | 2016 | 33 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 273 | 0.030 |
Why?
| | Hominidae | 1 | 1997 | 82 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 399 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1721 | 0.030 |
Why?
| | Frontal Lobe | 1 | 1997 | 146 | 0.030 |
Why?
| | Endoscopy | 1 | 1998 | 268 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 150 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2004 | 5752 | 0.030 |
Why?
| | Hemodynamics | | | 1097 | NaN |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.030 |
Why?
| | Ossification, Heterotopic | 1 | 2015 | 17 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 90 | 0.030 |
Why?
| | Dental Pulp | 1 | 1974 | 4 | 0.030 |
Why?
| | Caregivers | 1 | 2022 | 831 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 38 | 0.030 |
Why?
| | Radiotherapy Dosage | 1 | 2015 | 249 | 0.030 |
Why?
| | Essential Hypertension | 1 | 2014 | 5 | 0.030 |
Why?
| | Nutrition Assessment | 1 | 2015 | 86 | 0.030 |
Why?
| | Pregnancy | 1 | 2004 | 6274 | 0.030 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 1994 | 18 | 0.030 |
Why?
| | Periodontitis | 1 | 1974 | 49 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 108 | 0.030 |
Why?
| | Urban Population | 2 | 1990 | 442 | 0.030 |
Why?
| | Private Practice | 1 | 2014 | 20 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 823 | 0.030 |
Why?
| | Guided Tissue Regeneration | 1 | 2013 | 13 | 0.030 |
Why?
| | Bibliometrics | 1 | 2014 | 54 | 0.030 |
Why?
| | Outpatients | 1 | 2017 | 366 | 0.030 |
Why?
| | Polymers | 1 | 2017 | 475 | 0.030 |
Why?
| | Electric Stimulation Therapy | 1 | 1994 | 58 | 0.030 |
Why?
| | Acute Disease | 3 | 2015 | 984 | 0.030 |
Why?
| | Biological Evolution | 1 | 1997 | 428 | 0.030 |
Why?
| | Inpatients | 1 | 2017 | 456 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1297 | 0.030 |
Why?
| | Academies and Institutes | 1 | 2013 | 49 | 0.030 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 132 | 0.030 |
Why?
| | Sarcoma | 1 | 2015 | 174 | 0.030 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 598 | 0.030 |
Why?
| | France | 2 | 1990 | 30 | 0.030 |
Why?
| | Pulmonary Edema | 2 | 2012 | 106 | 0.030 |
Why?
| | Bone Neoplasms | 1 | 2015 | 227 | 0.020 |
Why?
| | North America | 1 | 2013 | 293 | 0.020 |
Why?
| | Sterilization | 1 | 2012 | 12 | 0.020 |
Why?
| | Intestinal Obstruction | 2 | 1991 | 48 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 377 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1024 | 0.020 |
Why?
| | Gamma Rays | 1 | 2012 | 52 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 734 | 0.020 |
Why?
| | Insurance, Health | 1 | 2014 | 270 | 0.020 |
Why?
| | Animals | 6 | 2019 | 34733 | 0.020 |
Why?
| | Temporomandibular Joint | 1 | 1991 | 9 | 0.020 |
Why?
| | Mental Disorders | 1 | 2000 | 1025 | 0.020 |
Why?
| | Denture, Complete | 1 | 1991 | 5 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 1991 | 10 | 0.020 |
Why?
| | Dentition | 1 | 1991 | 16 | 0.020 |
Why?
| | Joint Capsule Release | 1 | 2011 | 2 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 168 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 1570 | 0.020 |
Why?
| | Rhabdomyosarcoma | 1 | 1991 | 64 | 0.020 |
Why?
| | Educational Status | 1 | 2013 | 466 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2015 | 858 | 0.020 |
Why?
| | Retinoids | 1 | 1990 | 33 | 0.020 |
Why?
| | Epidemiologic Methods | 2 | 1988 | 75 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 10 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 758 | 0.020 |
Why?
| | Guanylate Cyclase | 1 | 1990 | 33 | 0.020 |
Why?
| | Intestine, Small | 1 | 1991 | 140 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 370 | 0.020 |
Why?
| | Bone Diseases | 1 | 1990 | 61 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2008 | 0.020 |
Why?
| | New York | 1 | 2009 | 127 | 0.020 |
Why?
| | Equipment Failure | 1 | 2009 | 112 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 52 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1063 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1989 | 110 | 0.020 |
Why?
| | DDT | 1 | 1988 | 1 | 0.020 |
Why?
| | Polychlorinated Biphenyls | 1 | 1988 | 9 | 0.020 |
Why?
| | Tooth, Deciduous | 1 | 1988 | 17 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 345 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2008 | 124 | 0.020 |
Why?
| | Michigan | 2 | 1985 | 105 | 0.020 |
Why?
| | Capsules | 1 | 2007 | 37 | 0.020 |
Why?
| | Lithotripsy | 1 | 2007 | 43 | 0.020 |
Why?
| | Placebos | 1 | 2007 | 203 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 77 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2007 | 106 | 0.020 |
Why?
| | Rodent Control | 1 | 1985 | 2 | 0.020 |
Why?
| | Rural Population | 1 | 1990 | 507 | 0.020 |
Why?
| | Leptospirosis | 1 | 1985 | 8 | 0.020 |
Why?
| | Tooth Diseases | 1 | 1985 | 13 | 0.020 |
Why?
| | Cardiomyopathies | 1 | 1989 | 334 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 2008 | 0.020 |
Why?
| | Tooth Extraction | 1 | 1985 | 28 | 0.020 |
Why?
| | Benzofurans | 1 | 1985 | 20 | 0.020 |
Why?
| | Amiodarone | 1 | 1985 | 25 | 0.020 |
Why?
| | Blood Gas Analysis | 2 | 2003 | 72 | 0.020 |
Why?
| | Environmental Exposure | 1 | 1990 | 479 | 0.020 |
Why?
| | Memory | 1 | 2007 | 231 | 0.020 |
Why?
| | Attitude to Health | 1 | 2008 | 430 | 0.010 |
Why?
| | Self Concept | 1 | 2006 | 237 | 0.010 |
Why?
| | Suburban Population | 1 | 1983 | 16 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 93 | 0.010 |
Why?
| | Serum Albumin | 1 | 2004 | 147 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 1969 | 0.010 |
Why?
| | Decision Making | 1 | 2011 | 842 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1985 | 142 | 0.010 |
Why?
| | Biopsy | 1 | 2007 | 1098 | 0.010 |
Why?
| | Attention | 1 | 2007 | 438 | 0.010 |
Why?
| | Bronchopneumonia | 2 | 1973 | 6 | 0.010 |
Why?
| | Patient Selection | 1 | 2007 | 685 | 0.010 |
Why?
| | Learning | 1 | 2007 | 381 | 0.010 |
Why?
| | Coronary Disease | 1 | 1985 | 389 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2010 | 808 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2003 | 178 | 0.010 |
Why?
| | Technetium | | | 11 | NaN |
Why?
| | Fourier Analysis | | | 38 | NaN |
Why?
| | Likelihood Functions | | | 136 | NaN |
Why?
| | Ifosfamide | 1 | 1999 | 33 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 573 | 0.010 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 1999 | 72 | 0.010 |
Why?
| | Death, Sudden, Cardiac | | | 179 | NaN |
Why?
| | Etoposide | 1 | 1999 | 148 | 0.010 |
Why?
| | Carboplatin | 1 | 1999 | 140 | 0.010 |
Why?
| | Collagen | 2 | 1991 | 433 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1994 | 1213 | 0.010 |
Why?
| | Cause of Death | | | 394 | NaN |
Why?
| | Disease-Free Survival | 1 | 1999 | 658 | 0.010 |
Why?
| | Stroke Volume | | | 588 | NaN |
Why?
| | Prevalence | 1 | 2004 | 2557 | 0.010 |
Why?
| | Animals, Zoo | 1 | 1997 | 12 | 0.010 |
Why?
| | Hylobates | 1 | 1997 | 8 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 1997 | 7 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 113 | 0.010 |
Why?
| | Lung | 1 | 1990 | 3928 | 0.010 |
Why?
| | Gorilla gorilla | 1 | 1997 | 22 | 0.010 |
Why?
| | Pan troglodytes | 1 | 1997 | 56 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 1999 | 543 | 0.010 |
Why?
| | Hypoxia | 3 | 1973 | 1073 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1997 | 156 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 567 | 0.010 |
Why?
| | Erythrocytes | | | 668 | NaN |
Why?
| | Electric Impedance | 1 | 1996 | 102 | 0.010 |
Why?
| | Pediatrics | 1 | 2003 | 1071 | 0.010 |
Why?
| | Stem Cells | 1 | 1999 | 572 | 0.010 |
Why?
| | Cell Movement | 1 | 1999 | 934 | 0.010 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1996 | 143 | 0.010 |
Why?
| | Dental Pulp Test | 1 | 1974 | 1 | 0.010 |
Why?
| | Alveolar Process | 1 | 1974 | 5 | 0.010 |
Why?
| | Tooth Mobility | 1 | 1974 | 6 | 0.010 |
Why?
| | Health Behavior | | | 755 | NaN |
Why?
| | Equipment Design | 1 | 1996 | 527 | 0.010 |
Why?
| | Temperature | 1 | 1996 | 634 | 0.010 |
Why?
| | Nerve Endings | 1 | 1972 | 5 | 0.010 |
Why?
| | Rib Fractures | 1 | 1972 | 33 | 0.010 |
Why?
| | Mandibular Condyle | 1 | 1991 | 6 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1972 | 418 | 0.010 |
Why?
| | Connective Tissue | 1 | 1991 | 39 | 0.010 |
Why?
| | Temporal Bone | 1 | 1991 | 51 | 0.010 |
Why?
| | Angiography | 1 | 1991 | 201 | 0.010 |
Why?
| | Atrophy | 1 | 1991 | 165 | 0.010 |
Why?
| | Nitroprusside | 1 | 1990 | 67 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 83 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1990 | 124 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 326 | 0.010 |
Why?
| | Solubility | 1 | 1990 | 234 | 0.010 |
Why?
| | Immunoblotting | 1 | 1990 | 303 | 0.010 |
Why?
| | Syncope | 1 | 1989 | 49 | 0.000 |
Why?
| | Skin Diseases | 1 | 1990 | 144 | 0.000 |
Why?
| | Heart Conduction System | 1 | 1989 | 91 | 0.000 |
Why?
| | Cardiac Pacing, Artificial | 1 | 1989 | 83 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1990 | 812 | 0.000 |
Why?
| | Calcinosis | 1 | 1990 | 255 | 0.000 |
Why?
| | Osteoporosis | 1 | 1990 | 233 | 0.000 |
Why?
| | Cattle | 1 | 1990 | 971 | 0.000 |
Why?
| | Psychotropic Drugs | 1 | 1986 | 66 | 0.000 |
Why?
| | Absenteeism | 1 | 1986 | 49 | 0.000 |
Why?
| | Oral Surgical Procedures, Preprosthetic | 1 | 1985 | 1 | 0.000 |
Why?
| | Tooth Eruption | 1 | 1985 | 9 | 0.000 |
Why?
| | Tooth Injuries | 1 | 1985 | 4 | 0.000 |
Why?
| | Malocclusion | 1 | 1985 | 25 | 0.000 |
Why?
| | Lung Diseases | 1 | 1972 | 757 | 0.000 |
Why?
| | Periodontal Diseases | 1 | 1985 | 63 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1986 | 511 | 0.000 |
Why?
| | Hypotension | 2 | 1972 | 124 | 0.000 |
Why?
| | Streptococcal Infections | 2 | 1973 | 146 | 0.000 |
Why?
| | Carbon Dioxide | 2 | 1973 | 261 | 0.000 |
Why?
| | Suicide | 1 | 1986 | 584 | 0.000 |
Why?
| | Respiration, Artificial | 2 | 1972 | 605 | 0.000 |
Why?
| | Rats | 1 | 1985 | 5244 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1973 | 28 | 0.000 |
Why?
| | Positive-Pressure Respiration | 1 | 1973 | 75 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1972 | 3 | 0.000 |
Why?
| | Anuria | 1 | 1972 | 4 | 0.000 |
Why?
| | Drowning | 1 | 1972 | 7 | 0.000 |
Why?
| | Embolism, Fat | 1 | 1972 | 11 | 0.000 |
Why?
| | Anti-Bacterial Agents | 2 | 1973 | 1719 | 0.000 |
Why?
| | Tracheotomy | 1 | 1972 | 24 | 0.000 |
Why?
| | Cyanosis | 1 | 1972 | 16 | 0.000 |
Why?
| | Mitral Valve Stenosis | 1 | 1972 | 22 | 0.000 |
Why?
| | Pneumococcal Infections | 1 | 1973 | 111 | 0.000 |
Why?
| | Blood Proteins | 1 | 1973 | 233 | 0.000 |
Why?
| | Shock | 1 | 1972 | 99 | 0.000 |
Why?
| | Heparin | 1 | 1972 | 252 | 0.000 |
Why?
| | Resuscitation | 1 | 1972 | 279 | 0.000 |
Why?
| | Hemorrhage | 1 | 1972 | 697 | 0.000 |
Why?
| | Oxygen | 1 | 1972 | 921 | 0.000 |
Why?
| | Influenza, Human | 1 | 1973 | 610 | 0.000 |
Why?
| | Pneumonia, Viral | 1 | 1972 | 361 | 0.000 |
Why?
| | Alcoholism | 1 | 1972 | 761 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|